Search Results - "M Bean, Lisa"

Survival of women with microinvasive adenocarcinoma of the cervix is not improved by radical surgery by Bean, Lisa M., MD, Ward, Kristy K., MD, Plaxe, Steven C., MD, McHale, Michael T., MD

“…Background Treatment for early-invasive adenocarcinoma of the cervix remains controversial. Although data have shown similar survival rates to those seen with…”
Get full text

A real-world comparison of the clinical and economic utility of OVA1 and CA125 in assessing ovarian tumor malignancy risk by Reilly, Gerard P, Gregory, David A, Scotti, Dennis J, Lederman, Samuel, Neiman, Wade A, Sussman, Steven, M Bean, Lisa, Ekono, Mercedes M

“…This largest-of-its-kind study evaluated the clinical utility of CA125 and OVA1, commonly used as ovarian tumor markers for assessing the risk of malignancy…”
Get full text

Intra-amniotic Fluconazole Therapy for Candida albicans Intra-amniotic Infection by Bean, Lisa M., Jackson, Jessica R., Dobak, William J., Beiswenger, Timothy R., Thorp, James A.

“…The consequences of intra-amniotic Candida infection can be devastating. Currently, standard management includes delivery. We identified only one previous case…”
Get full text

FAK activity sustains intrinsic and acquired ovarian cancer resistance to platinum chemotherapy by Diaz Osterman, Carlos J, Ozmadenci, Duygu, Kleinschmidt, Elizabeth G, Taylor, Kristin N, Barrie, Allison M, Jiang, Shulin, Bean, Lisa M, Sulzmaier, Florian J, Jean, Christine, Tancioni, Isabelle, Anderson, Kristen, Uryu, Sean, Cordasco, Edward A, Li, Jian, Chen, Xiao Lei, Fu, Guo, Ojalill, Marjaana, Rappu, Pekka, Heino, Jyrki, Mark, Adam M, Xu, Guorong, Fisch, Kathleen M, Kolev, Vihren N, Weaver, David T, Pachter, Jonathan A, Győrffy, Balázs, McHale, Michael T, Connolly, Denise C, Molinolo, Alfredo, Stupack, Dwayne G, Schlaepfer, David D

“…Gene copy number alterations, tumor cell stemness, and the development of platinum chemotherapy resistance contribute to high-grade serous ovarian cancer…”
Get full text

Squamous Cell Carcinoma of the Vulva Presenting as an Isolated Inguinal Lymph Node Metastasis: A Case Report by Kurnit, Katherine C, Bean, Lisa M, Plaxe, Steven C, Saenz, Cheryl C, McHale, Michael T

“…Vulvar carcinoma is usually diagnosed after a patient notices bleeding, pruritis, or a lesion. We describe a case of vulvar carcinoma presenting as an isolated…”
Get full text

Abstract A61: FAK activity sustains intrinsic and acquired ovarian cancer resistance to platinum chemotherapy by Osterman, Carlos J. Díaz, Ozmadenci, Duygu, Kleinschmidt, Elizabeth G., Taylor, Kristin N., Barrie, Allison M., Jiang, Shulin, Bean, Lisa M., Sulzmaier, Florian J., Li, Jian, Chen, Xiao Lei, Fu, Guo, Ojalill, Marjaana, Rappu, Pekka, Heino, Jyrki, Mark, Adam A., Xu, Guorong, Fisch, Kathleen M., Weaver, David T., Pachter, Jonathan A., Győrffy, Balázs, McHale, Michael T., Connolly, Denise C., Molinolo, Alfredo, Stupack, Dwayne G., Schlaepfer, David D.

“…Gene copy number alterations, tumor cell stemness, and development of platinum chemotherapy resistance contribute to high-grade serous ovarian cancer (HGSOC)…”
Get full text

Abstract NTOC-106: FAK INHIBITION RE–SENSITIZES PLATINUM–RESISTANT SEROUS OVARIAN CANCER by Bean, Lisa M., Sulzmaier, Florian J., Anderson, Kristen M., Tancioni, Isabelle, Butcher, Cheyenne R., Uryu, Sean, Jean, Christine, Lawson, Christine, Chen, Xiao Lei, Kleinschmidt, Elizabeth G., Kolev, Vihren N., Pachter, Jonathan A., Stupack, Dwayne G., Schlaepfer, David D.

“…Most ovarian cancer patients respond well to surgical debulking and platinum-taxol chemotherapy. However, ~80% of patients with a complete response to therapy…”
Get full text

Abstract 1991: Vulnerability of platinum-resistant ovarian cancer to FAK inhibition by Osterman, Carlos J. Diaz, Bean, Lisa M., Sulzmaier, Florian J., Taylor, Kristin N., Jiang, Shulin A., Tancioni, Isabelle, Anderson, Kristen, Jean, Christine, Chen, Xiao Lei, Kleinschmidt, Elizabeth G., Kolev, Vihren N., Weaver, David T., Pachter, Jonathan A., Connolly, Denise C., Molinolo, Alfredo, Schlaepfer, David D.

“…Platinum (CP)-resistant ovarian cancer (OC) has few effective treatment options. Adaptive chemotherapy resistance occurs in part through cancer stem cell (CSC)…”
Get full text

Abstract 3812: FAK inhibition resensitizes platinum-resistant serous ovarian cancer by Bean, Lisa M., Sulzmaier, Florian J., Tancioni, Isabelle, Uryu, Sean, Jean, Christine, Lawson, Christine, Chen, Xiao Lei, Kleinschmidt, Elizabeth G., Anderson, Kristen M., Cordasco, Edward A., Axelrod, Joshua, Kolev, Vihren N., Pachter, Jonathan A., Stupack, Dwayne G., Schlaepfer, David D.

“…Platinum and taxol administration is standard of care chemotherapy for serous ovarian cancer. Tumor recurrence occurs in a high percentage of patients, and…”
Get full text